At a glance
ClinicalIndex Comparison RecordN/ACompleted· 109 enrolled
Drug / intervention
Maestro +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Topcon 3D OCT-1 Maestro Optic Disc and RNFL Study: Agreement and Repeatability Comparison With the iVue
In Brief
A clinical study evaluating Maestro and iVue for Normal Healthy Subjects With No Known Ocular Diseases and 2 related conditions. Completed, enrolled 109 participants across 2 sites.
Detailed Summary
Assess the repeatability and agreement of the Optic Disc Parameters, Retinal Nerve Fiber Layer (RNFL) Thickness, and Full Retinal Thickness between the Maestro and iVue OCT devices
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNormal Healthy Subjects With No Known Ocular Diseases, Glaucomatous Eyes, Eyes With Retinal Diseases
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedOct 2014
Primary CompletionJan 2015
Study CompletionFeb 2015
TodayJul 2026
First PostedOct 28, 2014
Enrollment StartOct 1, 2014
Primary CompletionJan 1, 2015
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.7 years ago
Interventions
Maestrodevice
OCT machines used for diagnostic purposes
iVuedevice
OCT machines used for diagnostic purposes